• News & Events
  • East London Trust enhances QA workflow with excellence in quality assurance and treatment plan system verification

East London Trust enhances QA workflow with excellence in quality assurance and treatment plan system verification

Posted on Jan 16, 2018

Latest QA systems integrated to optimise workflow and increase testing accuracy

Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT) has updated its Quality Assurance (QA) portfolio to enhance QA workflow and treatment plan system verification. The range of systems in use with others soon to be deployed include COMPASS and Dolphin Patient QA from IBA, ImSimQA from Oncology Systems Limited and Modus Medical’s QUASAR Penta-Guide Phantom

The radiotherapy department is using the myQA global quality assurance system from IBA to connect all its QA applications, people and knowledge via a single cloud-based platform. This also provides access to IBA’s Compass, for 2-in-1 patient dose QA in 3D patient anatomy and the Stealth Chamber Reference Detector, a unique perturbation-free ‘beam invisible’ reference signal chamber for relative dosimetry. The Dolphin® Online Ready technology has also been selected to ensure efficient pre-treatment patient QA process.

With clinical variables such as patient anatomy and positioning, image quality and imaging devices subject to change, ImSimQA from Oncology Systems Limited offers extensive and flexible testing for a variety of deformable and rigid image registration scenarios, helping to increase the accuracy of testing and reducing the time needed to acquire test images. The QUASARPenta-Guide Phantom is used for the commissioning and daily testing of Image-Guided Radiotherapy (IGRT) systems, helping to minimise imaging artefacts by making use of its low-density objects to allow for rapid and easy daily testing.

“Quality Assurance in Radiotherapy is important to ensure the highest standard of care. Each step in the integrated treatment process needs control and checking to prevent errors and provide clinical confidence that patients are on the correct pathway for their condition,” states Ghirmay Kidane, Deputy Head of Radiotherapy Physics at BHRUT. “To boost our QA in the department, we identified that our two existing approaches of measurement-based and software-based patient QA needed integrating. By introducing COMPASS QA from IBA, that clinical requirement is satisfied. The two-in-one solution provides calculation-based, full 3-D independent treatment plan system verification and measurement-based quality assurance for the complete radiotherapy treatment chain delivered to our patients.”

“To further improve our testing and validation we introduced ImSimQA,” continues Ghirmay Kidane. “With ImSimQA, we are able to adhere to TG132, a Report that outlines the need for image registration and fusion techniques in radiotherapy planning. ImSimQA contains all the analysis tools that are needed for validation of image registrations. It can also generate datasets that can be imported into third-party image registration software for testing. These registration results can be imported back into ImSimQA for analysis, obtaining a pass or fail result.”

“Both machine and patient specific QA should be quick, easy and efficient. The Trust has boosted its technology selection by investing in the Oncology Systems’ portfolio and this has benefited them largely in delivering a much faster and safer workflow for patient treatments,” states Raj Baskara, Sales Specialist at Oncology Systems Limited. “We are committed to delivering leading-edge systems for Radiotherapy applications from our reputed global partners.”


(L to R): Raj Baskara, Oncology Systems Limited; Sarah Khan, healthcare science practitioner; Ryan Fullarton, trainee healthcare scientist; Ghirmay Kidane, Deputy Head of Radiotherapy Physics; Jose Sanchez, Principal Clinical Scientist.

This page was printed from OSL Web site at http://www.osl.uk.com